Studies have found that CDK4 and CDK6 are frequently overexpressed in pediatric B-ALL patients, with cancer cells relying on this pathway for excessive proliferation [51]. This evidence concerns the gene CDK6 and precursor B-cell acute lymphoblastic leukemia.